Novel Clinical Biomarkers for Drug-Induced Liver InjuryYouhao Chen, Min Huang, Huichang Bi et al.|Drug Metabolism and Disposition|2021Cited by 18
Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapyShaoxing Guan, Jinzhang Chen, Guosheng Yuan et al.|Drug Metabolism and Disposition|2025Cited by 2
The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegalyYue Gao, Huichang Bi, Shaoxing Guan et al.|Drug Metabolism and Disposition|2025Cited by 1